Cribstone Capital Management LLC boosted its position in shares of Teva Pharmaceutical Industries by 3.3% in the first quarter. Cribstone Capital Management LLC now owns 3,141 shares of the company's stock valued at $101,000 after buying an additional 100 shares in the last quarter. The company reported $1.38 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.36 by $0.02. Inc. bought a new stake in shares of Teva Pharmaceutical Industries during the fourth quarter worth approximately $577,310,000. CKW Financial Group acquired a new position in shares of Teva Pharmaceutical Industries during the third quarter worth about $168,000. Finally, Crow Point Partners LLC acquired a new position in shares of Teva Pharmaceutical Industries during the third quarter valued at $169,000.
Two other important profitability ratios for investors to know are both returns-based ratios that measure a company's ability to create wealth for shareholders.
Teva Pharmaceutical Industries Limited had its "outperform" rating reiterated by analysts at Cowen. The company reported its last quarter on 2/28/2017. Bank of America Corp upgraded Teva Pharmaceutical Industries from a "neutral" rating to a "buy" rating in a report on Tuesday, January 31st.
Taking a look at valuation rankings for Teva Pharmaceutical Industries Limited (NYSE:TEVA), we see that the stock has a Value Composite score of 28. The company's last traded volume of 17.09 million shares was above it's an average volume of 9.05 million shares. Shares are trading 8.14% above their 50-day moving average, and 2.14% below their 200-day moving average. Citigroup Inc reissued a "buy" rating and set a $47.00 target price on shares of Teva Pharmaceutical Industries in a research note on Tuesday, February 7th.
Teva Pharmaceutical Industries Limited (TEVA) now has the market capitalization of $31.84 Billion, P/E (price to earnings ttm) of 200.84 and Weekly volatility of 1.76% and monthly volatility of 1.73% respectively.
COPYRIGHT VIOLATION NOTICE: "Huntington National Bank Has $676,000 Stake in Teva Pharmaceutical Industries Ltd (TEVA)" was published by Markets Daily and is the property of of Markets Daily.
I'm not interested in talking about Ibrahimovic future, says Jose Mourinho
And Guardiola reckons the 35-year-old is already just as good as Barcelona star Sergio Busquets. The 34-year-old has scored 14 of the Black Cats' 27 goals in the 2016-17 Premier League season.
Institutional investors have recently made changes to their positions in the company.
Teva Pharmaceutical Industries Limited (TEVA) will report its next earnings on May 11 BMO. JFS Wealth Advisors LLC now owns 2,495 shares of the company's stock worth $115,000 after buying an additional 1,451 shares during the last quarter. According to their predictions High & Low revenue estimates are 6.07 Billion and 5.14 Billion respectively. Teva Pharmaceutical Industries had a return on equity of 17.46% and a net margin of 1.50%. The firm's quarterly revenue was up 33.0% on a year-over-year basis. It has a dividend yield of 0.00% and a 5 year dividend growth rate of -0.93%.
Teva Pharmaceutical Industries Limited (TEVA) is now trading with the volume of 3.88 Million. Equities analysts expect that Teva Pharmaceutical Industries will post $4.82 EPS for the current year.
02/10/2017 - Teva Pharmaceutical Industries Limited was downgraded to "underperform" by analysts at Mizuho.
Teva Pharmaceutical Industries Limited (TEVA) now has P/E (Price to Earnings) ratio of 200.94 while the company's industry has 29.08 P/E and the sector P/E is 29.95. They now have a United States dollars 42 price target on the stock. Sanford C. Bernstein reaffirmed an "outperform" rating and issued a $42.00 price objective on shares of Teva Pharmaceutical Industries in a report on Friday, February 24th. Looking at this figure it suggests that the shares of Teva Pharmaceutical Industries Limited (TEVA) may be overvalued, however, this can also depend upon the situation of the market; if the market is strong then it could suggest that Teva Pharmaceutical Industries Limited (TEVA) is a good investment, however if the market is weaker then it could suggest that the shares are undervalued. The stock gained a consensus recommendation of 2.4 on Zacks Investment Research where the scale runs from 1 to 5, 1 representing Strong buy and 5 showing Strong Sell.
Comments